A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

Clinical trial NCT07091630 · RECRUITING

Trial details

NCT number: NCT07091630
Sponsor: argenx
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Inflammatory Demyelinating Polyneuropathy CIDP Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Start date: 2025-09-16
Primary completion: 2027-10-07
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.